Composition
- Active ingredients
- RIFAMYCIN SODIUM EQ 194MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210910.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aemcolo
- Active substance
- rifamycin sodium
- Route
- Oral
- Dosage form
- Tablet, delayed release
- Applicant
- Cosmo Technologies
- Status
- Discontinued
- FDA approval
- 16 Nov 2018
- Application
- NDA210910-001